RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
12.03
-0.28 (-2.27%)
At close: Dec 19, 2025, 4:00 PM EST
12.17
+0.14 (1.16%)
After-hours: Dec 19, 2025, 7:49 PM EST
RxSight Market Cap
RxSight has a market cap or net worth of $494.63 million as of December 19, 2025. Its market cap has decreased by -71.57% in one year.
Market Cap
494.63M
Enterprise Value
278.68M
1-Year Change
-71.57%
Ranking
Category
Stock Price
$12.03
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $494.63M, an increase of 16.57%. That is a compound annual growth rate of 3.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 494.63M | -64.30% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |